Lv5
1160 积分 2023-03-20 加入
A single droplet digital PCR for ESR1 activating mutations detection in plasma
5天前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
3个月前
已完结
Multi-omic-based classification for identifying optimal neoadjuvant treatment strategies for high-risk early-stage breast cancer
4个月前
已完结
A systematic literature review of MTAP deletions in solid and hematologic Cancers
4个月前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial
5个月前
已完结
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
5个月前
已完结
A DNA‐Based Approach for the Forensic Identification of Asiatic Black Bear (Ursus thibetanus) in a Traditional Asian Medicine*
5个月前
已完结
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II study
7个月前
已完结
Switching ahead of progression: Insights from the SERENA-6 trial on targeting emerging ESR1 mutations in advanced HR+/HER2- breast cancer
7个月前
已关闭
A randomized phase 2 study of neratinib with or without fulvestrant for patients with HER2-positive, estrogen receptor-positive metastatic breast cancer
7个月前
已完结
皖公网安备34019202002308
